To provide a detailed genotype–phenotype correlation of retinal dysfunction in Duchenne muscular dystrophy (DMD) and specify the involvement of each retinal dystrophin isoform (Dp427, Dp260, Dp140, Dp71) in retinal pathology.
Key Findings:
Cumulative loss of dystrophin proteins correlates with increased severity of ERG alterations, suggesting a potential biomarker for monitoring disease progression.
Distinct dystrophin mutations lead to varying degrees of retinal dysfunction, indicating the need for personalized approaches in treatment.
ERG profiles can serve as indicators of central comorbidities in DMD, emphasizing the importance of retinal health in overall patient management.
Interpretation:
The study suggests that the severity of retinal dysfunction in DMD is influenced by the specific dystrophin isoforms lost due to mutations, highlighting the potential of ERG as a diagnostic tool for CNS-related dysfunctions and its role in guiding therapeutic strategies.
Limitations:
Diverse studies used different mouse models, equipment, and stimulation protocols, complicating direct comparisons and necessitating standardized methodologies in future research.
Limited understanding of Dp140's role in retinal function, indicating a gap in knowledge that warrants further investigation.
Conclusion:
This research enhances the understanding of how specific dystrophin mutations affect retinal physiology in DMD, advocating for the use of ERG in monitoring retinal dysfunction.
